Skip to main content
Equibles
LNAI logo

LNAI · Lunai Bioworks Inc.

Track LNAI — free

Use LNAI with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research LNAI.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$2.21 -0.07 (-2.86%)
Rebalance outlook locked
Going-concern doubt — flagged May 15, 2026

Substantial doubt about the company's ability to continue as a going concern.

“These conditions raise substantial doubt about the Company's ability to continue as a going concern for one year after the date the financial statements are issued.”
View the 10-Q filed May 15, 2026
Market Cap
$9.84M
Shares
4.53M

Price & Indicators

Drag to pan · scroll to zoom
Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$2.28 Open$2.25 Day$2.24–2.39 52W close$1.47–14.00 Avg vol 30d40K Short int174K · 3.8% float · 5.8d Short vol41% DataJan 2020–Sep 2026 Filing10-Q · May 15

Up next

Latest filing: 10-Q
filed May 15, 2026

Metrics snapshot

Useful current figures from the complete screener profile.

Revenue (TTM)
—
Trailing 12 months
Net income (TTM)
−$128.28M
Trailing 12 months
Revenue growth YoY
—
Year over year
Operating margin
—
Trailing 12 months
P / E (TTM)
—
Trailing earnings
FCF yield
—
TTM · current market cap
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Dividend yield
—
Trailing 12 months
Shares change YoY
+52.5%
Year over year · more shares
Price change (1Y)
—
Trailing year
Short interest
3.8%
Latest settlement · 5.8 days to cover
View all 115 metrics

Equibles Rating

blended score · not investment advice
Overall
Strong Sell
SellHoldBuy
Technical Strong Sell Momentum Weak Sentiment Bearish Fundamentals Poor Quant / Vol Very High
Market backdrop VIX 15.4 · calm Equity put/call 0.52
Technical
price trend
Strong Sell
50 / 200-day cross No cross
Price vs 200-day avg −43%
below
Price vs 50-day avg −5%
below
RSI (14) 47
neutral
MACD trend Negative
52-week position 6%
near low
Momentum
relative strength
Weak
1-month return +2%
trailing
6-month return −42%
trailing
YTD return −68%
this year
Relative strength −61%
vs S&P · 6-mo
Sentiment
smart money
Bearish
Trend (MA cross) No cross
50d $2 › 200d $4 — 200d above 50d
Institutional flow Distributing
-46% holders QoQ · +3 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Rising
3.85% of float · ▲ +11.8% MoM · 5.8 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr low
15 holders — near 1-yr low, contrarian setup
Squeeze score 59
elevated · 0–100
Fundamentals
Poor
EPS growth −19%
Y/Y
Free cash flow $-7.9M
Balance sheet $79.5K
net debt
Quant / Vol
risk profile
Very High
Volatility 225%
annualized · 1-yr
Max drawdown −89%
past year
ATR 10.3%
of price · 14-day

Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

Technicals

trend & momentum for long-term holders Strong Sell
4 · 2 · 0
50 / 200-day cross
No cross Neutral
Price vs 200-day avg
−43% Bearish
Price vs 50-day avg
−5% Bearish
RSI (14)
47 Neutral
MACD trend
Negative Bearish
52-week position
6% Bearish
Market signals — smart money & positioning
Bearish · 2 of 6
Trend (MA cross) No cross
50d $2 › 200d $4 — 200d above 50d
Institutional flow Distributing
-46% holders QoQ · +3 funds added
Insider flow Flat
No net insider activity over 90 days
Short interest Rising
3.85% of float · ▲ +11.8% MoM · 5.8 days cover
Volume signal Normal
Volume near normal
Institution breadth Multi-yr low
15 holders — near 1-yr low, contrarian setup
Price context
position in its 52-week range
Range low $1 Now $2 · 6% Range high $14
vs 200-day avg -43% vs 50-day avg -5%

Illustrative technical + ownership context — a signal mix, not investment advice.

Versus peers

Biotechnology — same industry group
Open screener →
Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
LNAI
Lunai Bioworks Inc.
this stock
$9.84M — — — 3.8%
VRTX
Vertex Pharmaceuticals Inc / Ma
 $130.06B +13.9% +46.2% 29.9 1.8%
REGN
Regeneron Pharmaceuticals, Inc.
 $79.83B +2.3% +20.8% 19.2 2.5%
ARGX
Argenx SE
 $60.93B +18.4% — — 2.0%
CSLLY
Csl Ltd
 $59.64B — — — 0.0%

Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

At a glance

key data from every section
Ownership
Institutional Holders Accumulating
Holders
15
% held
3.5%
Net QoQ
+35.1K sh
Top holder
Ground Swell Capital, LLC
Held Float
View
Held by Funds
Fund positions
5
View
Short & Settlement
Short Interest Rising
Shares short
174.3K
Days to cover
5.8d
Change
+18.3K sh
View
Short Volume
Short vol %
41%
As of
Sep 18, 2026
Short Total
View
Fails to Deliver
FTD shares
3.1K
Value
$7.3K
As of
Aug 31, 2026
View
Off-Exchange
Off-exchange %
49.6%
Week of
Aug 10, 2026
Off-exch Lit
View
Smart Money
Congressional Trades Sell
Member
Christopher L. Jacobs
Amount
$1.0K–$15.0K
Traded
Nov 8, 2022
View
Financials
Financials
Revenue (FY)
$0
Net income (FY)
$-178.0M
EPS diluted
$-86.40
View
Filings
SEC Filings
Latest
8-K
Filed
Jun 17, 2026
This year
14
View
Proposed Sales
Value
$1.7M
Shares
1.2M
Filed
Jun 11, 2024
View
Exempt Offerings
Offering
$106.8M
Filed
Feb 23, 2024
View
Earnings & Events
Investor Relations
Latest news
LUNAI BIOWORKS: CEO LETTER TO SHA…
Published
Jun 17, 2026
View

Performance

5D 20D 120D MTD YTD
LNAI -6.6% +2.5% -42.4% +0.0% -67.8%
SPY +0.6% -0.8% +18.2% -0.6% +11.8%
vs SPY -7.2% +3.3% -60.7% +0.6% -79.6%
Key facts CIK 1527728 CUSIP 29350E302 Visit website